A total of three targets have been selected for portfolio entry in the collaboration to date, with the potential to generate further future development milestones and sales-based royalty revenues for BenevolentAI
Bora establishes a leadership position in Taiwan's CDMO sector as it continues to expand into the global CDMO market
Digital PCR format allows for rapid turnaround time to facilitate fast and accurate post-transplant treatment decisions
Funds will be allocated to accelerate rapid production and high-end curation of whole genome sequences for its clinical application
Star Array's focus has been on the development of an automated (cassette-based) nucleic acid purification system coupled with its superfast nucleic acid amplification technology
Strive to empower public health with disinfection robotics solutions in post-pandemic era
Cedars-Sinai Medical Center Surgeon and Surgical Innovation Officer Dr. Jain joins the venture fund to bring clinical expertise to a portfolio of budding seed-stage healthcare companies
Researchers from the Tel Aviv University successfully engineer the world's first 3D human spinal cord tissue transplant
Company announced that it is accelerating its investment in its Leaps by Bayer impact investment unit with more than 1.3 billion euros funding until end of 2024
Approval is based on results of a multicenter, randomized, open-labeled and controlled IDE clinical study that demonstrated the superiority of Agili-C™ implant to the current surgical standard of care, debridement and microfracture in the knee joint
Subscribe To Our Newsletter & Stay Updated
